Since apoB is a causal determinant of atherosclerosis (9), and exposure to atherogenic lipoproteins across early adult life is a strong predictor of ASCVD risk (10, 11), it is important to understand normative apoB concentrations in young adults, their patterns and rates of change through midlife, and the predictors of change. This evidence concerns the gene APOB and atherosclerosis.